Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Animal health 'to suffer' without NI protocol changes
NOAH warns that up to half of veterinary products are at risk of being discontinued for the NI market.

NOAH chief executive calls for 'meaningful, constructive discussions'. 

The National Office of Animal Health (NOAH) has warned of an 'animal welfare catastrophe' unless changes are made to the Northern Ireland Protocol (NIP).

The animal health organisation fears that up to half of current veterinary medicines could disappear from the NI market should the UK government and the European Commission not reach an agreement by the end of the year.

NOAH chief executive Dawn Howard said: “NOAH member companies are extremely concerned about the implications of the NIP on their ability to fulfil regulatory requirements to maintain product authorisations, as well as its impact on supply chains. 

“The full Protocol in its current format will lead to NI specific requirements, from both a supply chain and regulatory perspective, that animal health companies are simply not able to meet. Many products – up to half – are at great risk of being discontinued for the NI market. NI vets and farmers will no longer have the tools they need to protect the animals in their care."

She continued: “The Northern Ireland Protocol Bill is not the answer. Unilateral action taken by the UK will leave our industry, with its global supply chain and rigorous regulatory standards, in an impossible position. 

“We need the UK government and European Commission to engage in meaningful, constructive discussions about this matter and develop a long-term solution to these problems to ensure long term availability and supply of veterinary medicines to the NI market.”

Agreed during Brexit negotiations, the NIP is a trading arrangement whereby goods may be transported across the Irish border without the need for checks. Current arrangements are due to cease by end of 2022, with the NIP to be applied in full from January 2023 onwards. 

It was anticipated that during this transitional phase, the UK government and the European Commission would decide on a clear course of action for the veterinary sector. However, NOAH says that despite talks recently resuming, there is little indication of such a result being obtained.

Ms Howard added: “We are encouraged by a reopening of dialogue about the NIP, but we need a swift solution for our sector’s problems to avert this potential animal welfare catastrophe.”

Her call echoes similar concerns raised by the British Veterinary Association and the North of Ireland Veterinary Association in recent months.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.